Keystone Capital Partners

Keystone Capital Partners provides capital solutions to help overlooked and underfunded companies reach their goals by providing a stable and equitable source of capital through creative investment structures. Keystone seeks to identify attractively valued micro-cap, small-cap, and mid-cap public and private equity investments through bottom-up, fundamental analysis.

Fredric Zaino

Founder, Managing Partner and Chief Investment Officer

4 past transactions

Adial Pharmaceuticals engages in the development of prescription medications for addiction and related disorders in the United States. The company's research pipeline includes AD04, a compound that completed the Phase IIb study for the treatment of alcohol use disorders; and AD01, which completed the Phase I clinical-stage for treating addictive behaviors.
Adial Pharmaceuticals engages in the development of prescription medications for addiction and related disorders in the United States. The company's research pipeline includes AD04, a compound that completed the Phase IIb study for the treatment of alcohol use disorders; and AD01, which completed the Phase I clinical-stage for treating addictive behaviors.
Anpac Bio-Medical Science is a biotechnology company that focuses on early cancer screening and detection. A variety of cancer screening and detection tests are carried out by AnPac Bio, including tests for biochemistry, immunology, genomics, and CDA (Cancer Differentiation Analysis). AnPaC Bio seeks to unite experts from various fields in order to create, disseminate, and implement accessible early disease detection tools.

Stella Diagnostics

Seed Round in 2020
Stella Diagnostics a is molecular diagnostics-based organization focused on improving patient management strategies for over 67 million people living with severe esophageal disease.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.